Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maha Hameed

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 1, 2024
Efficacy of lenvatinib <i>versus</i> sorafenib in the primary treatment of advanced hepatocellular carcinoma: A meta-analysisVikash Jaiswal, Maha Hameed, Sidra Naz, et al.
Cancers|March 14, 2026
A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment-USMIRC GroupMaha Hameed, Alma Habib, Abdullah Mohammad Khan, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Evaluation of Real-World Studies on Management of Relapsed Multiple Myeloma After BCMA-Directed Therapy Failure from U.S. Academic Centers and USMIRCNagham Youssef, Maha Hameed, Shebli Atrash, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 1, 2024
Efficacy of lenvatinib <i>versus</i> sorafenib in the primary treatment of advanced hepatocellular carcinoma: A meta-analysisVikash Jaiswal, Maha Hameed, Sidra Naz, et al.
Cancers|March 14, 2026
A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment-USMIRC GroupMaha Hameed, Alma Habib, Abdullah Mohammad Khan, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Evaluation of Real-World Studies on Management of Relapsed Multiple Myeloma After BCMA-Directed Therapy Failure from U.S. Academic Centers and USMIRCNagham Youssef, Maha Hameed, Shebli Atrash, et al.
Pageof 4